Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: Beginning of epidemic control

Autor: Thornton, V., Lennon, D., Rasanathan, K., O’Hallahan, J., Oster, P., Stewart, J., Tilman, S., Aaberge, I., Feiring, B., Nokleby, H., Rosenqvist, E., White, K., Reid, S., Mulholland, K., Wakefield, M.J., Martin, D.
Zdroj: In Vaccine 2006 24(9):1395-1400
Databáze: ScienceDirect